Drug class
Morpholine antifungal; topical antimycotic
Mechanism of action
Inhibits fungal sterol biosynthesis, principally at Δ14-reductase and Δ7–Δ8-isomerase steps, reducing ergosterol and causing accumulation of abnormal sterols in the fungal cell membrane.
General use cases
- Superficial fungal nail infections (onychomycosis)
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
